Authors:
Petracca, GM
Chemerinski, E
Starkstein, SE
Citation: Gm. Petracca et al., A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease, INT PSYCHOG, 13(2), 2001, pp. 233-240
Citation: Se. Starkstein et J. Kremer, The disinhibition syndrome and frontal-subcortical circuits, FRONTAL-SUBCORTICAL CIRCUITS IN PSYCHIATRIC AND NEUROLOGICAL DISORDERS, 2001, pp. 163-176
Citation: Ea. Fridman et Se. Starkstein, Treatment of depression in patients with dementia - Epidemiology, pathophysiology and treatment, CNS DRUGS, 14(3), 2000, pp. 191-201
Authors:
Rabinowicz, AL
Starkstein, SE
Leiguarda, RC
Coleman, AE
Citation: Al. Rabinowicz et al., Transient epileptic amnesia in dementia: A treatable unrecognized cause ofepisodic amnestic wandering, ALZ DIS A D, 14(4), 2000, pp. 231-233
Authors:
Robinson, RG
Schultz, SK
Castillo, C
Kopel, T
Kosier, JT
Newman, RM
Curdue, K
Petracca, G
Starkstein, SE
Citation: Rg. Robinson et al., Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: A placebo-controlled, double-blind study, AM J PSYCHI, 157(3), 2000, pp. 351-359
Authors:
Manes, F
Piven, J
Vrancic, D
Nanclares, V
Plebst, C
Starkstein, SE
Citation: F. Manes et al., An MRI study of the corpus callosum and cerebellum in mentally retarded autistic individuals, J NEUROP CL, 11(4), 1999, pp. 470-474
Authors:
Kuzis, G
Sabe, L
Tiberti, C
Merello, M
Leiguarda, R
Starkstein, SE
Citation: G. Kuzis et al., Explicit and implicit learning in patients with Alzheimer disease and Parkinson disease with dementia, NEUROPS NEU, 12(4), 1999, pp. 265-269